ElmoPedder14: Started Some Details Needs Work.

2025-12-08T11:14:09Z

Started Some Details Needs Work.

New page

{{Short description|Indian pharmaceutical company}}
{{Use dmy dates|date=July 2018}}
{{Use Indian English|date=July 2018}}
{{Infobox company
| name = Dishman Carbogen Amcis Limited
| logo = Dishman Carbogen Amcis.svg
| type = [[Public company|Public]]
| traded_as = {{ubl|{{NSE|DCAL}}|{{BSE|540701}}}}
| key_people = {{plainlist|
* Janmejay R. Vyas (Chairman)
* Arpit J. Vyas (Global Managing Director)
* Harshil R. Dalal (Global Chief Financial Officer)
* Himani Dhotre (Resigned)
}}
| industry = [[Pharmaceuticals]]
| products = Contract Research & Development, Contract Manufacturing New Molecules, HiPo Cat IV+, Contrast Media, Fine Chemicals, Vitamin D & Analogues, Formulation Development Fill & Finish, Softgels & HiPo Cat IV+ Parenteral.
| footnotes =
| foundation = 1983
| location = [[Ahmedabad]], [[Gujarat]], India<ref name=dish>{{cite web|url=http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=DISH:IN |archive-url=https://archive.today/20130118225733/http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=DISH:IN |url-status=dead |archive-date=18 January 2013 |title=DISHMAN PHARMACEUTICALS & CH (DISH:Natl India): Stock Quote & Company Profile - BusinessWeek |publisher=Investing.businessweek.com |date= |accessdate=2011-12-23}}</ref>
| revenue = {{up}} {{INRConvert|2440|c}} (FY23)<ref name="fy23"/>
| profit = {{down}} {{INRConvert|-29|c}} (FY23)<ref name="fy23">{{cite news |title=Dishman Carbogen Amcis Ltd Q4 FY2023 consolidated loss at Rs. 70.72 crores |url=https://www.equitybulls.com/category.php?id=332639 |access-date=24 June 2023 |work=EquityBulls |date=23 May 2023}}</ref>
| homepage = {{url|www.imdcal.com}}
}}
'''Dishman Carbogen Amcis Ltd''' is an Indian multinational pharmaceutical company specialized in the manufacture of [[active ingredients]] and [[Contract manufacturing organization|contract development and manufacturing]]. Dishman employs over 1,000 people worldwide{{Citation needed|date=December 2025}} and is listed on the [[Bombay Stock Exchange]] (BSE) and [[National Stock Exchange of India]] (NSE).

==History==
The Dishman Group was founded in 1983 by Janmejay R. Vyas, Managing Director of the Dishman Group. Since the beginning, the focus of the Dishman Group has been on research and development of various in-house technologies for the manufacture of [[quaternary ammonium compounds]] (quats) and active pharmaceutical ingredients. The first facility of the Dishman Group was built in 1987 in Naroda; in 1996 the company initiated its expansion at Bavla where it is currently headquartered. Through several acquisitions,<ref>{{Cite web |url=http://www.manufacturingchemist.com/technical/article_page/East_meets_West/38092 |title=East meets West |access-date=28 June 2012 |archive-date=4 March 2016 |archive-url=https://web.archive.org/web/20160304090325/http://www.manufacturingchemist.com/technical/article_page/East_meets_West/38092 |url-status=dead }}</ref> the Dishman Group became a global company with multiple manufacturing facilities in India, Europe and China serving pharmaceutical and biopharmaceutical companies.

==Company structure==
The Dishman Carbogen Amcis Group operates in two segments: [[Contract research organization|contract research services]] and marketable molecules such as bulk drugs, intermediates, [[quaternary ammonium compounds]] (quats), specialty chemicals and phase transfer catalysts. Dishman operates in four business units:

* Dishman Specialty Chemicals, which manufactures phase transfer catalysts, intermediates, fine chemicals, and products for the pharmaceutical, cosmetic and related industries.
* Dishman Vitamins and Chemicals, which manufactures vitamin D2, vitamin D3, vitamin D analogs, cholesterol and lanolin related products for pharmaceutical, cosmetic and related markets.
* Dishman Disinfectants, which manufactures antiseptic and disinfectant formulations.
* Dishman Custom Services, which includes Dishman contract research services and the subsidiary Carbogen Amcis. This business unit focuses on process research and development, API supply to support clinical trials, commercial manufacture of APIs.<ref>{{Cite web |url=http://www.carbogen-amcis.com/pdf/HPAPIs.pdf |title=Archived copy |access-date=28 June 2012 |archive-date=26 May 2012 |archive-url=https://web.archive.org/web/20120526143956/http://www.carbogen-amcis.com/pdf/HPAPIs.pdf |url-status=dead }}</ref> including cytotoxic and cytostatic drugs.

==Locations==
*[[Bavla]] and [[Naroda]] (Ahmedabad), India: Dishman Carbogen Amcis Ltd. The Naroda and Bavla sites are operational since 1989 and 1996, respectively. These sites manufacture phase transfer catalysts, pharmaceutical intermediates, active pharmaceutical ingredients and fine chemicals.
*[[Shanghai]], China: Dishman Carbogen Amcis (Shanghai) Co., Ltd. The site manufactures intermediates and active pharmaceutical ingredients, including highly potent drugs.
*[[Veenendaal]], The Netherlands: CARBOGEN AMCIS B.V manufactures of Vitamin D2, Vitamin D3, Vitamin D analogues, cholesterol and lanolin related products. The site was acquired from Solvay in 2007.<ref>{{Cite web |url=http://www.indodutchconnect.com/app/webroot/pdf/newslatter/issue_71/pharma_plans.pdf |title=Archived copy |access-date=28 June 2012 |archive-date=4 March 2016 |archive-url=https://web.archive.org/web/20160304002754/http://www.indodutchconnect.com/app/webroot/pdf/newslatter/issue_71/pharma_plans.pdf |url-status=dead }}</ref>
*[[Bubendorf]], Switzerland: CARBOGEN AMCIS AG. Founded in 1987 and acquired by Dishman in 2006.<ref name="busindasdadasdasdasdasdasess-standard.com">{{Cite news|url=http://www.business-standard.com/india/news/dishman-buys-swiss-pharma-major-carbogen/254653/|title = Dishman buys Swiss pharma major Carbogen|newspaper = Business Standard India|date = 24 August 2006}}</ref> The site supports the development and manufacture of active pharmaceutical ingredients, highly potents drugs and complex intermediate for clinical trials and commercial purposes.
*[[Aarau]] and [[Hunzenschwil]] Switzerland: CARBOGEN AMCIS AG. These sites operate since 1994 and 2000 and were acquired by Dishman in 2006.<ref name="busindasdadasdasdasdasdasess-standard.com" /> The Aarau and Hunzenschwill sites support the development and manufacture of active pharmaceutical ingredients and complex intermediate for clinical trials and commercial purposes.
*[[Vionnaz]] Switzerland: The facility was acquired by CARBOGEN AMCIS in 2014 and is designed to develop and manufac-ture highly potent APIs including the capability to produce highly potent warheads and linkers for antibody drug conjugates (ADCs).<ref name="Contract Pharma">{{cite web |last1=CONTRACT |first1=PHARMA |title=Completes successful Swissmedic inspection at Vionnaz, Switzerland. |url=https://www.contractpharma.com/contents/view_breaking-news/2022-10-06/carbogen-amcis-site-passes-inspection/ |access-date=10 June 2022 |website=Contract Pharma}}</ref>
*[[Riom]], France: CARBOGEN AMCIS SAS. Founded in 1998 and acquired by Dishman in 2012.<ref>{{Cite web|url=http://www.contractpharma.com/contents/view_breaking-news/2012-01-16/carbogen-amcis-acquires-creapharm-parenterals/|title = Carbogen Amcis Acquires Creapharm Parenterals}}</ref> The Riom site is focused on the development and production of sterile parenteral drugs for clinical trials.
*[[Manchester]], UK: CARBOGEN AMCIS Ltd. Operating since 1983 and acquired by Dishman in 2005.<ref>{{Cite web|last1=Com |first1=in-Pharmatechnologist |url=http://www.in-pharmatechnologist.com/Ingredients/Indian-CMO-expands-in-Europe-and-Middle-East|title=Indian CMO expands in Europe and Middle East}}</ref> The site focuses on non–[[Good manufacturing practice|GMP]] manufacture of complex intermediate for the pharmaceutical industry.

==References==
{{Reflist}}

==External links==
* {{official website|https://imdcal.com}}

[[Category:Pharmaceutical industry in Gujarat]]
[[Category:Pharmaceutical industry in India| ]]
[[Category:Pharmaceutical companies of Gujarat]]
[[Category:Pharmaceutical companies of India]]
[[Category:Companies listed on the Bombay Stock Exchange]]
[[Category:Companies listed on the National Stock Exchange of India]]
[[Category:Multinational companies headquartered in India]]
[[Category:Manufacturing companies based in Ahmedabad]]
[[Category:Pharmaceutical companies established in 1983]]
[[Category:1983 establishments in Gujarat]]

{{med-company-stub}}

Dishman Carbogen Amcis - Revision history

ElmoPedder14: Started Some Details Needs Work.